Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-578P (RNA, U6 small nuclear 578, pseudogene) is a genomic sequence classified as a pseudogene related to the U6 family of small nuclear RNAs. U6 snRNAs are essential components of the spliceosome, the cellular machinery responsible for pre-mRNA splicing[1][3]; however, pseudogenes like RNU6-578P lack the capability to yield functional RNA products or participate in splicing. Pseudogenes of U6 snRNA arise during evolution through duplication and mutation of genuine U6 snRNA genes, but do not contribute to normal cellular function. No experimental evidence indicates that RNU6-578P is transcribed, translated, or functionally relevant.[2][5] RNU6-578P is not a receptor, enzyme, or druggable target; it is a non-functional, pseudogenic segment related to U6 small nuclear RNA, with no established roles in disease, therapy, or cell biology. Its inclusion as a target is typically an error.[2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 578, pseudogene (RNU6-578P).